Tanox Biosystems, Inc.
Records under this name other than patents Tanox Biosystems, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Tanox Biosystems, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,657,050 | Chimeric viral-neutralizing immunoglobulins Formerly held Lapsed on the fee record Ended Dec 2, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 2, 2015 | From the USPTO record |
| US 6,197,298 | Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals Formerly held Lapsed on the fee record Ended Mar 6, 2013 · From the USPTO record | Lapsed on the fee record | Ended Mar 6, 2013 | From the USPTO record |
| US 6,129,916 | Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates Formerly held Lapsed on the fee record Ended Oct 10, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 10, 2012 | From the USPTO record |
| US 6,117,982 | Conjugates of microbeads and antibodies specific for T lymphocytes and their use as in vivo immune modulators Formerly held Lapsed on the fee record Ended Sep 12, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 12, 2012 | From the USPTO record |
| US 6,106,835 | Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators Formerly held Lapsed on the fee record Ended Aug 22, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2012 | From the USPTO record |
| US 6,072,035 | Reshaped monoclonal antibodies against an immunoglobulin isotype Lapsed on the fee record Ended Jun 6, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jun 6, 2012 | From the USPTO record |
| US 6,066,718 | Reshaped monoclonal antibodies against an immunoglobulin isotype Lapsed on the fee record Ended May 23, 2012 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2012 | From the USPTO record |
| US 6,685,930 | Methods and substances for recruiting therapeutic agents to solid tumors Formerly held Lapsed on the fee record Ended Feb 3, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 3, 2012 | From the USPTO record |
| US 6,309,880 | Antibodies specific for CD4-binding domain of HIV-1 Formerly held Lapsed on the fee record Ended Oct 30, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 30, 2009 | From the USPTO record |
| US 4,829,010 | Immunoassay device enclosing matrixes of antibody spots for cell determinations Term ended Term ended no later than May 9, 2009 · Low confidence | Term ended | Term ended no later than May 9, 2009 | Low confidence |